PR-924 T16568
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
PR-924 is a selective inhibitor of tripeptide epoxyketone immunoproteasome subunit LMP-7 (IC50: 22 nM). PR-924 inhibits growth and triggers apoptosis in multiple myeloma (MM) cells. PR-924 has antitumor activities. PR-924 covalently modifies proteasomal N
CAS nr:
1416709-79-9
Purity:
98%
Molecular Weight:
618,72
SMILES:
O=C(N[C@@H](CC1=CC=CC=C1)C([C@]2(CO2)C)=O)[C@@H](NC([C@@H](C)NC(C(CC3=CC=CC=C43)=C4C)=O)=O)CC5=CNC6=CC=CC=C56
Formula:
C37H38N4O5
Pathway:
Proteases/Proteasome,Ubiquitination
Target:
Proteasome,Proteasome
